Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A single session of 1 mA anodal tDCS-supported motor training does not improve motor performance in patients with multiple sclerosis.
Post subthalamic area deep brain stimulation for tremors: a mini-review.
[LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants].
Quality of life reporting in multiple sclerosis clinical trials: enough quality?
Glia Maturation Factor Induces Interleukin-33 Release from Astrocytes: Implications for Neurodegenerative Diseases.
Early White Matter Changes in Childhood Multiple Sclerosis: A Diffusion Tensor Imaging Study.
Autoantibody profiling in multiple sclerosis using arrays of human protein fragments.
Impact of Sativex(®) on quality of life and activities of daily living in patients with multiple sclerosis spasticity.
Associated Inosine to interferon: results of a clinical trial in multiple sclerosis.
Dimethyl fumarate confers neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage.
[Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy].
Anoctamin 2 identified as an autoimmune target in multiple sclerosis.
Angiotensin IV is Induced in Experimental Autoimmune Encephalomyelitis but Fails to Influence the Disease.
Influence of body mass index on psychological and functional outcomes in patients with multiple sclerosis: a cross-sectional study.
Temperature dependence of water diffusion pools in brain white matter.
Clinical Overview of Dalfampridine: An Agent With a Novel Mechanism of Action to Help With Gait Disturbances.
Understanding tremor in multiple sclerosis: prevalence, pathological anatomy, and pharmacological and surgical approaches to treatment.
Improving Multiple Sclerosis Plaque Detection Using a Semiautomated Assistive Approach.
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis.
The effectiveness of fingolimod in a Portuguese real-world population.
Chemokines and chemokine receptors in multiple sclerosis.
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
Central and peripheral demyelination.
Role of vitamin D in acquired immune and autoimmune diseases.
The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation.
Pages
« first
‹ previous
…
338
339
340
341
342
343
344
345
346
…
next ›
last »